# Vaxcyte, Inc. (PCVX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Vaxcyte, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PCVX/mda/fy2025/): filed 2026-02-24; accession 0001649094-26-000007 (https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/PCVX/mda/fy2024/): filed 2025-02-25; accession 0001649094-25-000028 (https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm)
- [FY 2023 MD&A](/company/PCVX/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021145 (https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm)
- [FY 2022 MD&A](/company/PCVX/mda/fy2022/): filed 2023-02-27; accession 0000950170-23-004654 (https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm)
- [FY 2021 MD&A](/company/PCVX/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002281 (https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm)

Back to /company/PCVX/